AP vs JELD

AP's deterministic health scores signal significant financial distress: the Piotroski F-Score of 2/9 indicates weak operational and financial health, while the absence of an Altman Z-Score raises red flags for potential bankruptcy risk. Despite a strong 12.3% YoY revenue growth and recent earnings surprises, the company reports negative net profit margins (-1.24%) and ROE (-4.08%), with a dangerously high debt/equity ratio of 1.88. The stock trades at a premium valuation (Forward P/E: 28.83, Price/Book: 2.23) despite poor profitability and no dividend, suggesting overvaluation. Technical trends are bearish, and insider activity is neutral, offering no conviction.

JELD is in a state of severe financial distress, evidenced by a critical Piotroski F-Score of 1/9 and a catastrophic Debt/Equity ratio of 14.81. The company is experiencing a death spiral characterized by negative profit margins (-19.34%), collapsing ROE (-174.72%), and consistent earnings misses (0/4 in the last year). While the Price/Sales ratio is nominally low at 0.04, this is a value trap given the negative growth and extreme leverage. The recent short-term price bounce is likely speculative and not supported by fundamental recovery.